Stock Scorecard
Stock Summary for Medtronic Plc (MDT) - $80.57 as of 4/23/2024 3:59:25 PM EST
Total Score
11 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MDT
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MDT
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MDT
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for MDT
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for MDT
Financial Details for MDT
Company Overview |
|
---|---|
Ticker | MDT |
Company Name | Medtronic Plc |
Country | USA |
Description | Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US. |
Sector Name | LIFE SCIENCES |
Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Most Recent Quarter | 1/31/2024 |
Next Earnings Date | 5/23/2024 |
Stock Price History |
|
Last Day Price | 80.57 |
Last Day Price Updated | 4/23/2024 3:59:25 PM EST |
Last Day Volume | 4,962,583 |
Average Daily Volume | 6,327,537 |
52-Week High | 89.04 |
52-Week Low | 67.71 |
Last Price to 52 Week Low | 18.99% |
Valuation Measures |
|
Trailing PE | 25.23 |
Industry PE | 46.24 |
Sector PE | 60.54 |
5-Year Average PE | 20.65 |
Free Cash Flow Ratio | 12.85 |
Industry Free Cash Flow Ratio | 21.71 |
Sector Free Cash Flow Ratio | 30.11 |
Current Ratio Most Recent Quarter | 2.30 |
Total Cash Per Share | 6.27 |
Book Value Per Share Most Recent Quarter | 38.95 |
Price to Book Ratio | 2.05 |
Industry Price to Book Ratio | 3.23 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 3.29 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.52 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 1,327,820,000 |
Market Capitalization | 106,982,457,400 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/21/2024 |
Last Dividend Amount | 0.69 |
Current Dividend Amount | 0.69 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 2.76 |
Trailing Annual Dividend Yield | 3.43% |
Forward Annual Dividend Rate | 2.95 |
Forward Annual Dividend Yield | 3.66% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 3.05% |
5-Year Average Dividend Yield | 2.60% |
1-Year Dividend Growth Rate Percentage | 3.00% |
3-Year Dividend Growth Rate Percentage | 5.52% |
5-Year Dividend Growth Rate Percentage | 6.72% |
All-Time Dividend Growth Rate Percentage | 15.48% |
Dividend Payout Ratio | 87.62% |
Income Statement |
|
Quarterly Earnings Growth YOY | 7.80% |
Annual Earnings Growth | -25.42% |
Reported EPS 12 Trailing Months | 3.15 |
Reported EPS Past Year | 3.75 |
Reported EPS Prior Year | 5.30 |
Net Income Twelve Trailing Months | 4,201,000,000 |
Net Income Past Year | 3,758,000,000 |
Net Income Prior Year | 5,039,000,000 |
Quarterly Revenue Growth YOY | 4.70% |
5-Year Revenue Growth | 1.52% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 8,321,000,000 |
Total Cash Past Year | 7,959,000,000 |
Total Cash Prior Year | 10,573,000,000 |
Net Cash Position Most Recent Quarter | -15,776,000,000 |
Net Cash Position Past Year | -40,959,000,000 |
Long Term Debt Past Year | 48,918,000,000 |
Long Term Debt Prior Year | 48,389,000,000 |
Total Debt Most Recent Quarter | 24,097,000,000 |
Equity to Debt Ratio Past Year | 0.51 |
Equity to Debt Ratio Most Recent Quarter | 0.68 |
Total Stockholder Equity Past Year | 51,483,000,000 |
Total Stockholder Equity Prior Year | 52,551,000,000 |
Total Stockholder Equity Most Recent Quarter | 51,792,000,000 |
Options |
|
Put/Call Ratio | 0.17 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -1.11 |
MACD Signal | -0.52 |
20-Day Bollinger Lower Band | 78.44 |
20-Day Bollinger Middle Band | 83.43 |
20-Day Bollinger Upper Band | 88.43 |
Beta | 0.78 |
RSI | 30.39 |
50-Day SMA | 81.33 |
200-Day SMA | 93.00 |
System |
|
Modified | 4/23/2024 5:32:17 AM EST |